Out today in Annals of Clinical and Translational Neurology: Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis. It only took 18 months to get here from the pre-print but hey, we were able to get longer follow-up!